JAN 2015 ARTICLE LIST >>
PharmaTutor (January- 2015)
ISSN: 2347 - 7881
(Volume 3, Issue 1)
Received On: 05/11/2014; Accepted On: 09/11/2014; Published On: 01/01/2015
AUTHORS: Bushra Shamim
Department of Pharmaceutics,
Faculty of Pharmacy,
Hamdard University, New Delhi, India
bushrashamim21@gmail.com
ABSTRACT: This is a review article on potential treatments for Ebola virus disease, also known as Ebola haemorrhagic fever. Ebola fever has emerged as one of the deadliest known forms of hemorrhagic fever since discovered in 1976. Transmission among humans occurs through the exchange of blood and body secretions. The Ebola virus causes an acute, serious illness which is often fatal if untreated. In this article experimental treatments like blood, immunological and drug therapies are discussed that are under development
How to cite this article: B Shamim; Deadly but Curable: A Review on Potential Treatments for Ebola Haemorrhagic Fever; PharmaTutor; 2015; 3(1); 14-18
[ABSTRACT WITH CITATION] [VIEW AS HTML]
REFERENCES:
1. Ebola virus disease., September 2014: http://www.who.int/mediacentre/factsheets/fs103/en/
2. Adrian M. C., Adeline M. N., Anthony S., Cam L. W., Heather S.; A Current Review of Ebola Virus: Pathogenesis, Clinical Presentation, and Diagnostic Assessment; Biol Res Nurs; 2003; (4):268
3. Ebola virus disease., October 2014: http://emedicine.medscape.com/article/216288-treatment#
4. Pollack., Andrew; Second drug is allowed for treatment of Ebola; The New York Times; 7 August 2014; Retrieved 8 August 2014.
5. Helen Branswell., Nancy Writebol; U.S. missionary, didn't get TKM-Ebola drug., Tekmira says, CBC News; Canadian Press; 3 August 2014.
6. Heald A.E., Iversen P.L., Saoud J.B., Sazani .P., Charleston J.S., Axtelle T., Wong M., Smith WB., Vutikullird A., Kaye E; Safety and pharmacokinetic profiles of phosphorodiamidate morpholino oligomers with activity against Ebola virus and Marburg virus: results of two single ascending dose studies; Antimicrobial Agents and Chemotherapy; 25 August 2014.
7. Kroll., David; How will we know if the Ebola drugs worked?; Forbes; 26 August 2014; Retrieved 1 October 2014.
8. Nathan Seppa; ZMapp drug fully protects monkey against Ebola; Science News- Society for Science & the Public; 29 August 2014; Retrieved 1 October 2014.
9. Ron Corben; Thai researchers claim breakthrough in Ebola treatment; Voice of America News; 3 October 2014
10. Blood transfusion named as priority treatment for Ebola; Nature; Retrieved 11 September 2014.
11. Use of convalescent whole blood or plasma collected from patients recovered from Ebola virus disease Empirical treatment during outbreaks; WHO; Retrieved 4 October
12. Statement on the WHO Consultation on potential Ebola therapies and vaccines; WHO; 5 September 2014; Retrieved 1 October 2014.
13. Mupapa K., Massamba M., Kibadi K., Kuvula K., Bwaka A., Kipasa M., Colebunders R., Muyembe-Tamfum J.J;Treatment of Ebola hemorrhagic fever with blood transfusions from convalescent patients: International Scientific and Technical Committee; J. Infect. Dis; 1999; 179 Suppl 1: S18–23.
14. Clark DV., Jahrling PB;, Lawler JV: Clinical management of filovirus-infected patients;; Viruses;, 2012; 4 (9) : 1668–86
15. Feldmann H., Geisbert T.W; Ebola haemorrhagic fever; Lancet; 5 March 2011: 849–62.
16. Saphire E.O; An update on the use of antibodies against the filoviruses; Immunotherapy; 2013; 5 (11) : 1221–33.
17. Gulland A; First Ebola treatment is approved by WHO; BMJ 349 ; Sep 08; 7 : 5539–5539.
18. Geisbert T.W., Lee A.C., Robbins M., Geisbert J.B., Honko A.N., Sood V., Johnson J.C., de Jong S., Tavakoli I., Judge A., Hensley L.E., Maclachlan I; Postexposure protection of non-human primates against a lethal Ebola virus challenge with RNA interference: A proof-of-concept study; The Lancet ; 29 May 2010 ; 375. 9729 : 1896–1905.
19. Warren TK., Warfield KL., Wells J., Swenson DL., Donner KS., Van Tongeren SA., Garza NL., Dong L., Mourich DV., Crumley S., Nichols DK., Iversen PL., Bavari S; Advanced antisense therapies for postexposure protection againstlethal filovirus infections; Nature Medicine; September 2010 ; 16(9) : 991–994.
.png)
